NM_024411.5:c.436A>C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_024411.5(PDYN):​c.436A>C​(p.Met146Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00673 in 1,614,150 control chromosomes in the GnomAD database, including 64 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M146K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0051 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0069 ( 61 hom. )

Consequence

PDYN
NM_024411.5 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -2.41

Publications

9 publications found
Variant links:
Genes affected
PDYN (HGNC:8820): (prodynorphin) The protein encoded by this gene is a preproprotein that is proteolytically processed to form the secreted opioid peptides beta-neoendorphin, dynorphin, leu-enkephalin, rimorphin, and leumorphin. These peptides are ligands for the kappa-type of opioid receptor. Dynorphin is involved in modulating responses to several psychoactive substances, including cocaine. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010]
PDYN-AS1 (HGNC:53462): (PDYN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0040592253).
BP6
Variant 20-1980652-T-G is Benign according to our data. Variant chr20-1980652-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 337839.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 776 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDYNNM_024411.5 linkc.436A>C p.Met146Leu missense_variant Exon 4 of 4 ENST00000217305.3 NP_077722.1 P01213

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDYNENST00000217305.3 linkc.436A>C p.Met146Leu missense_variant Exon 4 of 4 1 NM_024411.5 ENSP00000217305.2 P01213

Frequencies

GnomAD3 genomes
AF:
0.00510
AC:
776
AN:
152162
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00367
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0130
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00788
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.00492
AC:
1236
AN:
251432
AF XY:
0.00472
show subpopulations
Gnomad AFR exome
AF:
0.000923
Gnomad AMR exome
AF:
0.00179
Gnomad ASJ exome
AF:
0.000496
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0124
Gnomad NFE exome
AF:
0.00745
Gnomad OTH exome
AF:
0.00456
GnomAD4 exome
AF:
0.00690
AC:
10088
AN:
1461870
Hom.:
61
Cov.:
32
AF XY:
0.00669
AC XY:
4867
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.000836
AC:
28
AN:
33480
American (AMR)
AF:
0.00150
AC:
67
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000497
AC:
13
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000406
AC:
35
AN:
86258
European-Finnish (FIN)
AF:
0.0127
AC:
677
AN:
53420
Middle Eastern (MID)
AF:
0.00329
AC:
19
AN:
5768
European-Non Finnish (NFE)
AF:
0.00805
AC:
8948
AN:
1111988
Other (OTH)
AF:
0.00498
AC:
301
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
664
1328
1992
2656
3320
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
320
640
960
1280
1600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00510
AC:
776
AN:
152280
Hom.:
3
Cov.:
32
AF XY:
0.00526
AC XY:
392
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.00101
AC:
42
AN:
41564
American (AMR)
AF:
0.00366
AC:
56
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.0130
AC:
138
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00788
AC:
536
AN:
68016
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
45
90
136
181
226
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00517
Hom.:
6
Bravo
AF:
0.00399
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.00778
AC:
30
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00744
AC:
64
ExAC
AF:
0.00463
AC:
562
EpiCase
AF:
0.00714
EpiControl
AF:
0.00670

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PDYN: BP4, BS2 -

Sep 15, 2022
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Spinocerebellar ataxia type 23 Benign:3
Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 28, 2017
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jun 24, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
0.0020
DANN
Benign
0.69
DEOGEN2
Benign
0.13
T;T;T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.0043
N
LIST_S2
Benign
0.41
.;T;.
MetaRNN
Benign
0.0041
T;T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.86
L;L;L
PhyloP100
-2.4
PrimateAI
Benign
0.27
T
PROVEAN
Benign
0.14
N;N;N
REVEL
Benign
0.12
Sift
Benign
0.39
T;T;T
Sift4G
Benign
0.39
T;T;T
Polyphen
0.0
B;B;B
Vest4
0.13
MutPred
0.32
Loss of catalytic residue at M146 (P = 0.0268);Loss of catalytic residue at M146 (P = 0.0268);Loss of catalytic residue at M146 (P = 0.0268);
MVP
0.38
MPC
0.026
ClinPred
0.0027
T
GERP RS
-9.4
Varity_R
0.044
gMVP
0.15
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77155664; hg19: chr20-1961298; API